| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |